Horizon Pharma Inc  

(Public, NASDAQ:HZNP)   Watch this stock  
Find more results for Ronald Watkins�
13.37
+0.19 (1.44%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.88 - 13.98
52 week 2.11 - 18.30
Open 13.20
Vol / Avg. 2.13M/3.72M
Mkt cap 916.70M
P/E     -
Div/yield     -
EPS -2.33
Shares 68.56M
Beta     -
Inst. own 79%
May 5, 2014
Q1 2014 Horizon Pharma Inc Earnings Release (Estimated) Add to calendar
Mar 28, 2014
Horizon Pharma Inc at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference
Mar 27, 2014
Horizon Pharma Inc Corporate Update
Mar 19, 2014
Horizon Pharma Inc to Acquire Vidara Therapeutics International Ltd.
Mar 13, 2014
Q4 2013 Horizon Pharma Inc Earnings Release
Mar 13, 2014
Q4 2013 Horizon Pharma Inc Earnings Conference Call
Mar 10, 2014
Horizon Pharma Inc at ROTH Conference
Mar 3, 2014
Horizon Pharma Inc at Cowen Health Care Conference
Feb 11, 2014
Horizon Pharma Inc at Biotechnology Industry Organization CEO & Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -390.18% -201.31%
Operating margin -21.85% -57.90%
EBITD margin - -45.32%
Return on average assets -200.94% -66.73%
Return on average equity -3967.27% -523.78%
Employees 247 -
CDP Score - -

Address

Suite 520, 520 Lake Cook Road
DEERFIELD, IL 60062
United States - Map
+1-224-3833000 (Phone)
+1-224-3833001 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.

Officers and directors

Timothy P. Walbert Chairman of the Board, President, Chief Executive Officer
Age: 45
Bio & Compensation  - Reuters
Robert J. De Vaere Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Robert F. Carey III Executive Vice President, Chief Business Officer
Bio & Compensation  - Reuters
Jeffrey W. Sherman M.D. Chief Medical Officer, Executive Vice President - Development, Regulatory Affairs, Manufacturing
Age: 58
Bio & Compensation  - Reuters
Todd N. Smith Executive Vice President, Chief Commercial Officer
Age: 43
Bio & Compensation  - Reuters
Michael G. Grey Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
H. Thomas Watkins Director
Age: 61
Bio & Compensation  - Reuters
Jeffrey W. Bird M.D., Ph.D. Independent Director
Age: 52
Bio & Compensation  - Reuters
Jeff Himawan Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
Ronald E. Pauli Independent Director
Age: 52
Bio & Compensation  - Reuters